# QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration

> **NCT06766565** · PHASE1 · COMPLETED · sponsor: **Fuzhou General Hospital** · enrollment: 15 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** QYJD Compound Preparation

## Key facts

- **NCT ID:** NCT06766565
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-08
- **Primary completion:** 2022-12-08
- **Final completion:** 2023-12-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06766565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06766565, "QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06766565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*